Skip to main content
QTRX
NASDAQ Life Sciences

Quanterix Reports Q4 Net Loss of $23.1 Million Amidst Negative Operating Income

feedReported by Reuters
Sentiment info
Negative
Importance info
8
Price
$6.33
Mkt Cap
$295.679M
52W Low
$4.05
52W High
$8.77
Market data snapshot near publication time

summarizeSummary

Quanterix Corporation announced a net loss of $23.117 million for the fourth quarter, alongside an operating loss of $24.751 million and basic EPS of -$0.49. The company reported Q4 product revenue of $29.218 million and a gross profit of $20.038 million, which was significantly offset by $44.789 million in operating expenses. These results indicate continued financial challenges for the company, with substantial losses relative to its market capitalization. Traders will be closely watching for any further details on cost management or revenue growth strategies in upcoming communications.

At the time of this announcement, QTRX was trading at $6.33 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $295.7M. The 52-week trading range was $4.05 to $8.77. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Reuters.


show_chartPrice Chart

Share this article

Copied!

feed QTRX - Latest Insights

QTRX
Apr 24, 2026, 8:10 AM EDT
Filing Type: DEF 14A
Importance Score:
7
QTRX
Mar 02, 2026, 4:35 PM EST
Filing Type: 10-K
Importance Score:
8
QTRX
Mar 02, 2026, 4:28 PM EST
Filing Type: 8-K
Importance Score:
8
QTRX
Mar 02, 2026, 4:04 PM EST
Source: Dow Jones Newswires
Importance Score:
8
QTRX
Mar 02, 2026, 4:01 PM EST
Source: Reuters
Importance Score:
8
QTRX
Jan 08, 2026, 4:46 PM EST
Filing Type: 8-K
Importance Score:
9